Free tool
Healthcare stocks
We cover 1,115 companies in the Healthcare sector. The median market value in the group is $42.72M, measured across the 1,000 largest of them. Among those 1,000, the median move over the past trading day is +0.26%. 42% of the 974 with a 200-day average trade above it. Price change over the past year runs from −74.0% to +100.1% across the middle 80 percent of the group, with a median of −15.5%. Among those 1,000, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
1,115 of 2,199 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| R1DY34.SA | Dr. Reddy's Laboratories Limited | $9.95B | Mid cap | −21.76% |
| PODD | Insulet Corporation | $9.92B | Mid cap | −56.52% |
| NUVL | Nuvalent Inc | $9.79B | Mid cap | +67.40% |
| BIO-B | Bio-Rad Laboratories, Inc. | $9.77B | Mid cap | +47.78% |
| AVTR | Avantor, Inc. | $9.75B | Mid cap | +9.16% |
| OSCR | Oscar Health, Inc. | $9.55B | Mid cap | +85.10% |
| TWST | Twist Bioscience Corporation | $9.50B | Mid cap | +452.83% |
| WDH1.DE | Demant A/S | $9.39B | Mid cap | −5.53% |
| DEMANT.CO | Demant A/S | $9.37B | Mid cap | +17.33% |
| SYRE | Spyre Therapeutics, Inc. | $9.32B | Mid cap | +547.53% |
| KRK.WA | Krka, d. d. | $9.12B | Mid cap | +31.52% |
| PCVX | Vaxcyte, Inc. | $9.09B | Mid cap | +100.62% |
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +182.02% |
| IMVT | Immunovant, Inc. | $8.95B | Mid cap | +192.14% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| HQY | HealthEquity, Inc. | $8.83B | Mid cap | +20.55% |
| 4523.T | Eisai Co., Ltd. | $8.67B | Mid cap | +9.74% |
| BRKR | Bruker Corporation | $8.66B | Mid cap | +64.93% |
| ATR | AptarGroup, Inc. | $8.57B | Mid cap | −2.35% |
| 4151.T | Kyowa Kirin Co., Ltd. | $8.51B | Mid cap | +3.09% |
| TGTX | TG Therapeutics, Inc. Common Stock | $8.48B | Mid cap | +96.32% |
| TXG | 10x Genomics, Inc. | $8.43B | Mid cap | +359.99% |
| ALKS | Alkermes plc | $8.26B | Mid cap | +69.69% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $7.78B | Mid cap | +14.26% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% |
| HIMS | Hims & Hers Health, Inc. | $7.41B | Mid cap | −26.15% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | $7.39B | Mid cap | +62.22% |
| 2413.T | M3, Inc. | $7.39B | Mid cap | −20.12% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| RHC.AX | Ramsay Health Care Limited | $7.33B | Mid cap | +18.74% |
| HNGE | Hinge Health, Inc. | $7.25B | Mid cap | +63.19% |
| ALK-B.CO | ALK-Abelló A/S | $7.23B | Mid cap | +8.24% |
| SHL.AX | Sonic Healthcare Limited | $7.20B | Mid cap | −11.60% |
| CHE | Chemed Corporation | $7.11B | Mid cap | +19.61% |
| SRRK | Scholar Rock Holding Corporation | $7.09B | Mid cap | +74.77% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +21.56% |
| PACS | PACS Group, Inc. | $7.00B | Mid cap | +272.69% |
| CGON | CG Oncology, Inc. | $7.00B | Mid cap | +210.58% |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +8.33% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +13.26% |
| ORKA | Oruka Therapeutics, Inc. | $6.74B | Mid cap | +601.72% |
| 7747.T | Asahi Intecc Co., Ltd. | $6.68B | Mid cap | +58.61% |
| RADL3.SA | Raia Drogasil S.A. | $6.65B | Mid cap | +12.04% |
| E2XE34.SA | Exelixis, Inc. | $6.61B | Mid cap | +23.92% |
| HLUN-B.CO | H. Lundbeck A/S | $6.61B | Mid cap | +5.61% |
| LNTH | Lantheus Holdings, Inc. | $6.58B | Mid cap | +79.61% |
| HLUN-A.CO | H. Lundbeck A/S | $6.55B | Mid cap | +26.06% |
| BLTE | Belite Bio, Inc | $6.51B | Mid cap | +154.13% |
| 3088.T | MatsukiyoCocokara & Co. | $6.45B | Mid cap | −14.17% |
| COGT | Cogent Biosciences, Inc. | $6.39B | Mid cap | +212.13% |
| COH.AX | Cochlear Limited | $6.38B | Mid cap | −53.16% |
| LQDA | Liquidia Corporation | $6.31B | Mid cap | +168.53% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | Mid cap | +138.24% |
| AMRX | Amneal Pharmaceuticals, Inc. | $6.24B | Mid cap | +93.10% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $6.17B | Mid cap | +142.74% |
| BLCO | Bausch + Lomb Corporation | $6.16B | Mid cap | +18.72% |
| ERAS | Erasca, Inc. | $6.16B | Mid cap | +1016.98% |
| BLCO.TO | Bausch + Lomb Corporation | $6.15B | Mid cap | +18.08% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $6.13B | Mid cap | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $6.13B | Mid cap | +378.90% |
| STVN | Stevanato Group S.p.A. | $6.08B | Mid cap | +3.23% |
| TVTX | Travere Therapeutics, Inc. | $6.06B | Mid cap | +288.91% |
| CTEC.L | Convatec Group PLC | $6.06B | Mid cap | −2.30% |
| RDNT | RadNet, Inc. | $6.05B | Mid cap | +10.45% |
| DFTX | Definium Therapeutics, Inc. | $6.02B | Mid cap | +354.92% |
| T1FX34.SA | Teleflex Incorporated | $6.00B | Mid cap | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $5.98B | Mid cap | +36.58% |
| TFX | Teleflex Incorporated | $5.94B | Mid cap | +10.85% |
| CRSP | CRISPR Therapeutics AG | $5.89B | Mid cap | +12.51% |
| XENE | Xenon Pharmaceuticals Inc. | $5.85B | Mid cap | +58.42% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −19.07% |
| LGND | Ligand Pharmaceuticals Incorporated | $5.62B | Mid cap | +77.42% |
| MMED | MiniMed Group, Inc. | $5.60B | Mid cap | +2.33% |
| SHC | Sotera Health Company | $5.57B | Mid cap | +19.04% |
| MMSI | Merit Medical Systems, Inc. | $5.44B | Mid cap | +3.32% |
| GRFS | Grifols, S.A. | $5.44B | Mid cap | −17.62% |
| ACAD | ACADIA Pharmaceuticals Inc. | $5.23B | Mid cap | +20.73% |
| HAE | Haemonetics Corporation | $4.93B | Mid cap | +96.13% |
| DYN | Dyne Therapeutics, Inc. | $4.92B | Mid cap | +102.62% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | $4.89B | Mid cap | −14.48% |
| EWTX | Edgewise Therapeutics, Inc. | $4.80B | Mid cap | +209.16% |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% |
| LFST | LifeStance Health Group, Inc. | $4.69B | Mid cap | +127.83% |
| 000100.KS | Yuhan Corporation | $4.67B | Mid cap | −25.59% |
| WAY | Waystar Holding Corp. | $4.64B | Mid cap | −32.56% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.63B | Mid cap | −11.37% |
| ICUI | ICU Medical, Inc. | $4.56B | Mid cap | +44.85% |
| OBCK.DE | Ottobock SE & Co. KGaA I | $4.51B | Mid cap | −0.82% |
| DOCS | Doximity, Inc. | $4.51B | Mid cap | −62.74% |
| RLAY | Relay Therapeutics, Inc. | $4.51B | Mid cap | +486.04% |
| ELVN | Enliven Therapeutics, Inc. | $4.48B | Mid cap | +205.89% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | $4.47B | Mid cap | +80.49% |
| CELC | Celcuity Inc. | $4.44B | Mid cap | +87.35% |
| CON | Concentra Group Holdings Parent, Inc. | $4.44B | Mid cap | +49.74% |
| NVST | Envista Holdings Corporation | $4.39B | Mid cap | +30.07% |
| LIVN | LivaNova PLC | $4.37B | Mid cap | +40.92% |
| HTFL | Heartflow, Inc. | $4.34B | Mid cap | +67.19% |
| ITGR | Integer Holdings Corporation | $4.25B | Mid cap | +15.26% |
| INDV | Indivior Pharmaceuticals, Inc. | $4.24B | Mid cap | +49.81% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +107.18% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.17B | Mid cap | +340.71% |
| ANN.AX | Ansell Limited | $4.17B | Mid cap | +22.31% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.16B | Mid cap | −2.73% |
| LEGN | Legend Biotech Corporation | $4.14B | Mid cap | −38.44% |
| TNGX | Tango Therapeutics, Inc. | $4.13B | Mid cap | +264.73% |
| MANE | Veradermics, Incorporated | $4.11B | Mid cap | +171.13% |
| IDYA | IDEAYA Biosciences, Inc. | $4.10B | Mid cap | +71.91% |
| IRTC | iRhythm Holdings, Inc. | $4.06B | Mid cap | −25.71% |
| ABCL | AbCellera Biologics Inc. | $4.05B | Mid cap | +195.51% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.04B | Mid cap | −0.90% |
| RCUS | Arcus Biosciences, Inc. | $4.02B | Mid cap | +211.03% |
| VKTX | Viking Therapeutics, Inc. | $3.99B | Mid cap | +32.19% |
| DNLI | Denali Therapeutics Inc. | $3.98B | Mid cap | +60.12% |
| TLX | Telix Pharmaceuticals Limited | $3.96B | Mid cap | −4.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.91B | Mid cap | −10.12% |
| TLX.AX | Telix Pharmaceuticals Limited | $3.91B | Mid cap | −12.72% |
| BBZA.DE | BB Biotech AG | $3.90B | Mid cap | +7.22% |
| 000105.KS | Yuhan Corporation | $3.88B | Mid cap | −31.05% |
| CAMX.ST | Camurus AB (publ) | $3.87B | Mid cap | −14.52% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | Mid cap | +52.72% |
| FIE.DE | Fielmann Group AG | $3.85B | Mid cap | −30.39% |
| IOVA | Iovance Biotherapeutics, Inc. | $3.82B | Mid cap | +233.60% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | $3.80B | Mid cap | +22.85% |
| 7459.T | MediPal Holdings Corporation | $3.77B | Mid cap | +14.74% |
| GRAL | GRAIL, Inc. | $3.69B | Mid cap | +150.69% |
| OGN | Organon & Co. | $3.61B | Mid cap | +52.78% |
| A2LC34.SA | Alcon Inc. | $3.57B | Mid cap | −12.91% |
| GPCR | Structure Therapeutics Inc. | $3.56B | Mid cap | +168.82% |
| QURE | uniQure N.V. | $3.54B | Mid cap | +228.30% |
| OPCH | Option Care Health, Inc. | $3.54B | Mid cap | −15.75% |
| VCYT | Veracyte, Inc. Common Stock | $3.54B | Mid cap | +49.04% |
| NHC | National HealthCare Corporation | $3.52B | Mid cap | +103.48% |
| PLSE | Pulse Biosciences, Inc. | $3.50B | Mid cap | +197.94% |
| ZEAL.CO | Zealand Pharma A/S | $3.48B | Mid cap | −27.05% |
| IMNM | Immunome, Inc. | $3.34B | Mid cap | +196.22% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $3.33B | Mid cap | +275.00% |
| MBX | MBX Biosciences, Inc. | $3.30B | Mid cap | +394.02% |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.27B | Mid cap | −27.10% |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.27B | Mid cap | +10.69% |
| AFX.DE | Carl Zeiss Meditec AG | $3.26B | Mid cap | −23.23% |
| WRBY | Warby Parker Inc. | $3.24B | Mid cap | −0.61% |
| BIOA-B.ST | BioArctic AB (publ) | $3.24B | Mid cap | +20.03% |
| CLDX | Celldex Therapeutics, Inc. | $3.24B | Mid cap | +87.96% |
| TMDX | TransMedics Group, Inc. | $3.23B | Mid cap | −18.59% |
| VIRP.PA | Virbac SA | $3.22B | Mid cap | −2.81% |
| BEAM | Beam Therapeutics Inc. | $3.21B | Mid cap | +88.75% |
| AMBU-B.CO | Ambu A/S | $3.20B | Mid cap | −19.61% |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.20B | Mid cap | +26.21% |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.19B | Mid cap | −28.33% |
| IRON | Disc Medicine, Inc. | $3.16B | Mid cap | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $3.12B | Mid cap | +58.44% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $3.03B | Mid cap | −22.60% |
| HYPE3.SA | Hypera S.A. | $2.98B | Mid cap | −4.08% |
| ALMS | Alumis Inc. | $2.98B | Mid cap | +388.98% |
| AVAH | Aveanna Healthcare Holdings Inc. | $2.97B | Mid cap | +82.91% |
| ZLAB | Zai Lab Limited | $2.94B | Mid cap | −23.10% |
| BKD | Brookdale Senior Living Inc. | $2.91B | Mid cap | +59.90% |
| SLS | SELLAS Life Sciences Group, Inc. | $2.89B | Mid cap | +637.70% |
| ALHC | Alignment Healthcare, Inc. | $2.82B | Mid cap | −12.77% |
| ACHC | Acadia Healthcare Company, Inc. | $2.78B | Mid cap | +34.73% |
| 9989.T | Sundrug Co.,Ltd. | $2.76B | Mid cap | −17.00% |
| RGC | Regencell Bioscience Holdings Limited | $2.74B | Mid cap | −54.89% |
| VRDN | Viridian Therapeutics, Inc. | $2.74B | Mid cap | +30.21% |
| ATAI | AtaiBeckley Inc. | $2.74B | Mid cap | +56.96% |
| NRIX | Nurix Therapeutics, Inc. | $2.73B | Mid cap | +178.70% |
| EBO.AX | EBOS Group Limited | $2.72B | Mid cap | −35.38% |
| PRVA | Privia Health Group, Inc. | $2.71B | Mid cap | −0.93% |
| AXGN | AxoGen, Inc. Common Stock | $2.68B | Mid cap | +237.59% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| SUPN | Supernus Pharmaceuticals, Inc. | $2.62B | Mid cap | +2.09% |
| PHVS | Pharvaris N.V. | $2.62B | Mid cap | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.61B | Mid cap | −9.60% |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% |
| B72.DE | AtaiBeckley Inc. | $2.60B | Mid cap | +57.16% |
| CURA.TO | Curaleaf Holdings, Inc. | $2.60B | Mid cap | +225.42% |
| EMEIS.PA | EMEIS | $2.60B | Mid cap | +10.18% |
| PGEN | Precigen, Inc. | $2.60B | Mid cap | +82.91% |
| BV3.DE | BAVARIAN NORDIC N | $2.59B | Mid cap | +14.47% |
| BAVA.CO | Bavarian Nordic A/S | $2.58B | Mid cap | −10.13% |
| 2784.T | Alfresa Holdings Corporation | $2.57B | Mid cap | +7.97% |
| TRVI | Trevi Therapeutics, Inc. | $2.56B | Mid cap | +146.57% |
| VERA | Vera Therapeutics, Inc. | $2.54B | Mid cap | +65.32% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% |
| BHC.TO | Bausch Health Companies Inc. | $2.52B | Mid cap | −8.00% |
| NKTR | Nektar Therapeutics | $2.52B | Mid cap | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $2.51B | Mid cap | +17.16% |
| BHC | Bausch Health Companies Inc. | $2.50B | Mid cap | −7.81% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.50B | Mid cap | +6.99% |
| NUVB | Nuvation Bio Inc. | $2.49B | Mid cap | +146.53% |
| KOD | Kodiak Sciences Inc. | $2.48B | Mid cap | +316.68% |
| ATRC | AtriCure, Inc. | $2.48B | Mid cap | +28.65% |
| PBH | Prestige Consumer Healthcare Inc. | $2.46B | Mid cap | −21.64% |
| RAPP | Rapport Therapeutics, Inc. | $2.46B | Mid cap | +249.76% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.44B | Mid cap | +63.50% |
| ONT.L | Oxford Nanopore Technologies plc | $2.44B | Mid cap | −14.60% |
| DMP.DE | Dermapharm Holding SE | $2.43B | Mid cap | +14.86% |
| BFLY | Butterfly Network, Inc. | $2.41B | Mid cap | +483.23% |
| OCUL | Ocular Therapeutix, Inc. | $2.39B | Mid cap | −8.34% |
| GRDN | Guardian Pharmacy Services, Inc. | $2.36B | Mid cap | +42.20% |
| UFPT | UFP Technologies, Inc. | $2.36B | Mid cap | +37.69% |
| MLYS | Mineralys Therapeutics, Inc. | $2.32B | Mid cap | +78.70% |
| 009420.KS | Hanall Biopharma Co., Ltd. | $2.32B | Mid cap | +108.57% |
| COAG | Hemab Therapeutics Holdings, Inc. | $2.32B | Mid cap | +46.03% |
| ALMR | Alamar Biosciences, Inc. | $2.29B | Mid cap | +50.09% |
| GENB | Generate Biomedicines, Inc. | $2.27B | Mid cap | +61.11% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.27B | Mid cap | +4.09% |
| URGN | UroGen Pharma Ltd. | $2.27B | Mid cap | +150.59% |
| EKTA-B.ST | Elekta AB (publ) | $2.27B | Mid cap | +19.21% |
| ADUS | Addus HomeCare Corporation | $2.26B | Mid cap | +3.81% |
| 008930.KS | Hanmi Science Co., Ltd. | $2.26B | Mid cap | +10.13% |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | −3.82% |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +9.42% |
| AUPH | Aurinia Pharmaceuticals Inc. | $2.23B | Mid cap | +38.03% |
| VCEL | Vericel Corporation | $2.21B | Mid cap | +20.76% |
| ZBIO | Zenas BioPharma, Inc. | $2.20B | Mid cap | +103.93% |
| CLOV | Clover Health Investments, Corp. | $2.19B | Mid cap | +56.14% |
| MD | Pediatrix Medical Group, Inc. | $2.19B | Mid cap | +58.21% |
| XRAY | DENTSPLY SIRONA Inc. | $2.19B | Mid cap | −21.70% |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% |
| XNCR | Xencor, Inc. Common Stock | $2.18B | Mid cap | +265.79% |
| EXE.TO | Extendicare Inc. | $2.18B | Mid cap | +147.28% |
| BHVN | Biohaven Ltd. | $2.17B | Mid cap | −3.75% |
| 9987.T | Suzuken Co., Ltd. | $2.17B | Mid cap | −11.16% |
| STOK | Stoke Therapeutics, Inc. | $2.16B | Mid cap | +77.32% |
| CLOV34.SA | Clover Health Investments, Corp. | $2.15B | Mid cap | +44.32% |
| ESTA | Establishment Labs Holdings Inc. | $2.15B | Mid cap | +77.45% |
| GN.CO | GN Store Nord A/S | $2.15B | Mid cap | −19.72% |
| KLRA | Kailera Therapeutics, Inc. | $2.14B | Mid cap | −31.73% |
| ADMA | ADMA Biologics, Inc. | $2.14B | Mid cap | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $2.14B | Mid cap | +195.71% |
| 302440.KS | SK bioscience Co.,Ltd. | $2.13B | Mid cap | −22.23% |
| HCM | HUTCHMED (China) Limited | $2.13B | Mid cap | −23.04% |
| HCM.L | HUTCHMED (China) Limited | $2.12B | Mid cap | −21.24% |
| NANO.PA | Nanobiotix S.A. | $2.12B | Mid cap | +341.09% |
| NBTX | Nanobiotix S.A. | $2.11B | Mid cap | +321.42% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
| GNS.L | Genus plc | $2.08B | Mid cap | −13.32% |
| NEU.AX | Neuren Pharmaceuticals Limited | $2.08B | Mid cap | +18.47% |
| PIII | P3 Health Partners Inc. | $2.06B | Mid cap | +35.72% |
| CMPS | COMPASS Pathways plc | $2.06B | Mid cap | +224.89% |
| NVCR | NovoCure Limited | $2.05B | Mid cap | +50.60% |
| SEM | Select Medical Holdings Corp | $2.05B | Mid cap | +26.87% |
| 6960.T | Fukuda Denshi Co., Ltd. | $2.02B | Mid cap | +78.59% |
| TSHA | Taysha Gene Therapies, Inc. | $2.02B | Mid cap | +112.33% |
| PRGO | Perrigo Company plc | $2.01B | Mid cap | −36.97% |
| EMBLA.CO | Embla Medical hf | $2.00B | Mid cap | −5.76% |
| KLRS | Kalaris Therapeutics, Inc. | $99.98M | Micro cap | +67.33% |
| GOSS | Gossamer Bio, Inc. | $99.97M | Micro cap | −91.33% |
| ILA.AX | Island Pharmaceuticals Limited | $99.59M | Micro cap | +104.35% |
| 4BB.L | 4basebio PLC | $99.32M | Micro cap | −46.89% |
| NANOFS.ST | Nanoform Finland Oyj | $99.24M | Micro cap | +12.70% |
| ATRA | Atara Biotherapeutics, Inc. | $98.77M | Micro cap | −19.61% |
| PARK | Park Dental Partners, Inc. | $98.64M | Micro cap | +99.61% |
| CGTX | Cognition Therapeutics, Inc. | $97.95M | Micro cap | −67.61% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $97.76M | Micro cap | +14.33% |
| 4563.T | AnGes, Inc. | $97.73M | Micro cap | −56.67% |
| ABNX.PA | ABIONYX Pharma SA | $97.56M | Micro cap | −16.20% |
| 88Q.DE | 4basebio PLC | $96.74M | Micro cap | −46.70% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $96.60M | Micro cap | −22.41% |
| NANOFH.HE | Nanoform Finland Oyj | $96.13M | Micro cap | +13.49% |
| 4575.T | CanBas Co., Ltd. | $96.08M | Micro cap | −40.51% |
| BIOPOR.CO | BioPorto A/S | $95.88M | Micro cap | −6.25% |
| ADOC.PA | Adocia SA | $94.62M | Micro cap | −46.72% |
| FBIO | Fortress Biotech, Inc. | $94.38M | Micro cap | +23.58% |
| PLYX | Polaryx Therapeutics, Inc. | $94.21M | Micro cap | −94.66% |
| 004080.KS | Shinhung Co., Ltd | $94.21M | Micro cap | +2.17% |
| BB1.AX | BLINKLAB FPO [BB1] | $93.89M | Micro cap | +67.65% |
| ALDX | Aldeyra Therapeutics, Inc. | $93.51M | Micro cap | −73.14% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +63.91% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +4.58% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $92.86M | Micro cap | −8.15% |
| ALC.AX | Alcidion Group Limited | $92.38M | Micro cap | −7.62% |
| HYPR | Hyperfine, Inc. | $92.24M | Micro cap | −30.42% |
| INIFY.OL | INIFY Laboratories AB | $91.74M | Micro cap | +34.00% |
| VISTN.OL | Vistin Pharma ASA | $91.18M | Micro cap | −15.47% |
| SGMO | Sangamo Therapeutics, Inc. | $91.14M | Micro cap | −56.86% |
| DWTX | Dogwood Therapeutics, Inc. | $91.10M | Micro cap | −47.04% |
| 4350.T | Medical System Network Co., Ltd. | $90.54M | Micro cap | +6.47% |
| NANEXA.ST | Nanexa AB (publ) | $90.50M | Micro cap | +109.51% |
| 4978.T | ReproCELL Incorporated | $90.50M | Micro cap | −17.32% |
| 214390.KS | Kyongbo Pharmaceutical Co., Ltd | $90.27M | Micro cap | +10.80% |
| EAH.L | ECO Animal Health Group plc | $90.13M | Micro cap | +37.41% |
| CVRX | CVRx, Inc. | $89.78M | Micro cap | −54.77% |
| 7V0.DE | Novogenia AG | $89.68M | Micro cap | −29.07% |
| RLYB | Rallybio Corporation | $89.67M | Micro cap | +262.65% |
| 3417.T | Ohki Healthcare Holdings Co.,Ltd. | $89.57M | Micro cap | −15.91% |
| ICCC | ImmuCell Corporation | $89.37M | Micro cap | +61.58% |
| ACH | Accendra Health, Inc. | $89.21M | Micro cap | −77.39% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $88.96M | Micro cap | −23.95% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $88.88M | Micro cap | +76.27% |
| OSE.PA | OSE Immunotherapeutics SA | $88.77M | Micro cap | −47.82% |
| 6678.T | Techno Medica Co., Ltd. | $88.56M | Micro cap | +10.19% |
| 194A.T | WOLVES HAND CO LTD | $88.26M | Micro cap | +100.75% |
| CWEB.TO | Charlotte's Web Holdings, Inc. | $88.25M | Micro cap | +246.15% |
| 001360.KS | SAMSUNG PHARM. Co., LTD. | $87.90M | Micro cap | −21.42% |
| 002390.KS | HANDOK Inc. | $87.90M | Micro cap | −20.23% |
| AALR3.SA | Alliança Saúde e Participações S.A. | $87.29M | Micro cap | −52.27% |
| TENX | Tenax Therapeutics, Inc. | $86.82M | Micro cap | −60.81% |
| SERA | Sera Prognostics, Inc. | $86.00M | Micro cap | −17.42% |
| MAIA | MAIA Biotechnology, Inc. | $85.78M | Micro cap | −10.76% |
| CTOR | Citius Oncology, Inc. | $85.68M | Micro cap | −57.14% |
| ECOR | electroCore, Inc. | $85.38M | Micro cap | +79.70% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +39.60% |
| CREO.L | Creo Medical Group PLC | $85.36M | Micro cap | −1.90% |
| 4574.T | Taiko Pharmaceutical Co.,Ltd. | $85.35M | Micro cap | −10.10% |
| EQL.ST | EQL Pharma AB | $84.50M | Micro cap | −67.71% |
| ACET | Adicet Bio, Inc. | $84.25M | Micro cap | −20.89% |
| HIGH.DE | Cantourage Group SE | $83.91M | Micro cap | +45.19% |
| VRCA | Verrica Pharmaceuticals Inc. | $83.66M | Micro cap | −17.53% |
| 7792.T | Colan Totte.Co.,Ltd. | $83.45M | Micro cap | +4.31% |
| OBI.L | Ondine Biomedical Inc. | $83.31M | Micro cap | −25.76% |
| AB.PA | AB Science S.A. | $83.30M | Micro cap | −44.83% |
| RPID | Rapid Micro Biosystems, Inc. | $83.26M | Micro cap | −37.12% |
| GANX | Gain Therapeutics, Inc. | $83.14M | Micro cap | +3.53% |
| 002620.KS | Jeil Pharma Holdings Inc | $83.00M | Micro cap | −14.27% |
| POLB.L | Poolbeg Pharma PLC | $82.75M | Micro cap | +161.54% |
| HLS.TO | HLS Therapeutics Inc. | $82.45M | Micro cap | −26.86% |
| 4888.T | Stella Pharma Corporation | $82.15M | Micro cap | −9.23% |
| OKYO | OKYO Pharma Limited | $81.87M | Micro cap | −35.80% |
| TELO | Telomir Pharmaceuticals, Inc. | $81.15M | Micro cap | −19.18% |
| ATH.AX | Alterity Therapeutics Limited | $81.04M | Micro cap | −20.00% |
| ATHE | Alterity Therapeutics Limited | $81.02M | Micro cap | −12.35% |
| RCE.AX | Recce Pharmaceuticals Ltd | $81.01M | Micro cap | −12.79% |
| OM | Outset Medical, Inc. | $80.92M | Micro cap | −68.62% |
| DH | Definitive Healthcare Corp. | $80.51M | Micro cap | −81.10% |
| CRDF | Cardiff Oncology, Inc. | $79.35M | Micro cap | −53.85% |
| OMDA.OL | Omda AS | $79.27M | Micro cap | −27.31% |
| ELTX | Elicio Therapeutics, Inc. | $79.11M | Micro cap | −72.71% |
| DICOT.ST | Dicot Pharma AB | $78.52M | Micro cap | −76.93% |
| NXTMH.HE | Nexstim Plc | $78.40M | Micro cap | −30.34% |
| MDG.WA | Medicalgorithmics S.A. | $77.94M | Micro cap | −21.33% |
| ANVS | Annovis Bio, Inc. | $77.54M | Micro cap | −18.75% |
| MNOV | MediciNova, Inc. | $77.28M | Micro cap | +18.94% |
| 7775.T | Daiken Medical Co., Ltd. | $77.26M | Micro cap | −3.06% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +318.64% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −24.66% |
| NRXS | NeurAxis, Inc. | $76.23M | Micro cap | +137.80% |
| ZTEK | Zentek Ltd. | $76.16M | Micro cap | −7.46% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.37% |
| 7097.T | SAKURASAKU PLUS,Co.,Ltd. | $75.31M | Micro cap | −0.70% |
| 4875.T | MediciNova, Inc. | $75.15M | Micro cap | +15.24% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −23.49% |
| IBIO | iBio, Inc. | $73.03M | Micro cap | +72.94% |
| KOO.L | Kooth plc | $72.99M | Micro cap | −6.94% |
| DRIO | DarioHealth Corp. | $72.42M | Micro cap | −32.82% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +141.55% |
| STX.L | Shield Therapeutics plc | $70.81M | Micro cap | −41.98% |
| SPRO | Spero Therapeutics, Inc. | $70.76M | Micro cap | −33.51% |
| SAR.L | Sareum Holdings plc | $70.74M | Micro cap | +38.10% |
| MDXH | MDxHealth SA | $70.73M | Micro cap | −83.84% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −28.13% |
| ALTHX.PA | THX Pharma Société Anonyme | $70.40M | Micro cap | +89.35% |
| 7702.T | JMS Co.,Ltd. | $70.30M | Micro cap | +6.67% |
| 2689.T | OLBA HEALTHCARE HOLDINGS, Inc. | $69.91M | Micro cap | −7.22% |
| EXOZ | eXoZymes, Inc. | $69.89M | Micro cap | −19.12% |
| PMVP | PMV Pharmaceuticals, Inc. | $69.76M | Micro cap | −8.10% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +254.22% |
| ZLNA.OL | Zelluna ASA | $69.57M | Micro cap | +45.70% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | $69.28M | Micro cap | +30.77% |
| CSBR | Champions Oncology, Inc. | $69.19M | Micro cap | −29.46% |
| 9341.T | GENOVA, Inc. | $69.07M | Micro cap | +2.20% |
| RNTX | Rein Therapeutics Inc. | $69.01M | Micro cap | −32.20% |
| NNOX | Nano-X Imaging Ltd. | $67.82M | Micro cap | −77.81% |
| LDX.AX | Lumos Diagnostics Holdings Limited | $67.70M | Micro cap | −19.23% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | $67.44M | Micro cap | −15.92% |
| INMB | INmune Bio Inc. | $67.44M | Micro cap | +8.48% |
| BOLD | Boundless Bio, Inc. | $67.33M | Micro cap | +160.18% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +2.98% |
| 2934.T | J Frontier Co.,Ltd. | $66.96M | Micro cap | +5.78% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −52.13% |
| MAAT.PA | MaaT Pharma SA | $66.80M | Micro cap | −39.58% |
| HYFT | MindWalk Holdings Corp. | $66.72M | Micro cap | −48.55% |
| ONCO.ST | Oncopeptides AB (publ) | $66.64M | Micro cap | −65.91% |
| HEALTH.HE | Nightingale Health Oyj | $65.41M | Micro cap | −58.91% |
| LTP.AX | LTR PHARMA FPO [LTP] | $65.08M | Micro cap | −2.00% |
| GENT.OL | Gentian Diagnostics ASA | $64.73M | Micro cap | −30.56% |
| AJ91.DE | DocCheck AG | $64.58M | Micro cap | −9.24% |
| LYTIX.OL | Lytix Biopharma ASA | $64.24M | Micro cap | −14.82% |
| ALGAE.PA | FERMENTALG | $64.20M | Micro cap | −10.79% |
| R0L.F | J Frontier Co.,Ltd. | $64.15M | Micro cap | −43.48% |
| RNXT | RenovoRx, Inc. | $64.08M | Micro cap | +58.13% |
| TLPH | Talphera, Inc. | $63.84M | Micro cap | +108.77% |
| IMA | ImageneBio, Inc. | $63.80M | Micro cap | −60.78% |
| SEZI.ST | Senzime AB (publ) | $62.78M | Micro cap | −41.72% |
| AHC.AX | Austco Healthcare Limited | $61.76M | Micro cap | −36.11% |
| 3079.T | DVx Inc. | $61.76M | Micro cap | −7.86% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | $61.74M | Micro cap | +124.11% |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | $61.73M | Micro cap | +31.66% |
| HRTX | Heron Therapeutics, Inc. | $61.34M | Micro cap | −76.59% |
| HVO.L | hVIVO plc | $61.06M | Micro cap | −34.60% |
| 4263.T | SUSMED,Inc. | $60.39M | Micro cap | −29.83% |
| INKT | MiNK Therapeutics, Inc. | $60.32M | Micro cap | −21.89% |
| 9265.T | Yamashita Health Care Holdings,Inc. | $59.98M | Micro cap | +24.36% |
| XLO | Xilio Therapeutics, Inc. | $59.75M | Micro cap | −7.35% |
| NTRB | Nutriband Inc. | $58.71M | Micro cap | −24.59% |
| MYO | Myomo, Inc. | $58.62M | Micro cap | +35.78% |
| DXR | Daxor Corporation | $58.38M | Micro cap | −7.83% |
| V3V.DE | FamiCord AG | $58.21M | Micro cap | −60.69% |
| 3446.T | JTEC Corporation | $58.17M | Micro cap | +29.85% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | $57.90M | Micro cap | −2.93% |
| EPIS-B.ST | Episurf Medical AB (publ) | $57.85M | Micro cap | +73.96% |
| 4524.T | Morishita Jintan Co., Ltd. | $57.77M | Micro cap | +4.07% |
| FLUO.ST | FluoGuide A/S | $57.76M | Micro cap | −21.07% |
| COCH | Envoy Medical, Inc. | $57.66M | Micro cap | −33.30% |
| SRTS | Sensus Healthcare, Inc. | $57.45M | Micro cap | +7.35% |
| BVC.L | BATM Advanced Communications Ltd. | $57.08M | Micro cap | −24.80% |
| IMM.AX | Immutep Limited | $57.02M | Micro cap | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | $56.97M | Micro cap | −13.53% |
| 7776.T | CellSeed Inc. | $56.74M | Micro cap | −47.42% |
| 4896.T | K Pharma,Inc. | $56.45M | Micro cap | +15.89% |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% |
| ATYR | aTyr Pharma, Inc. | $55.91M | Micro cap | −88.95% |
| 4584.T | Kidswell Bio Corporation | $55.83M | Micro cap | −24.37% |
| 4572.T | Carna Biosciences, Inc. | $55.69M | Micro cap | +83.26% |
| GNTA | Genenta Science S.p.A. | $55.45M | Micro cap | −67.05% |
| COIL.L | Coiled Therapeutics plc | $55.33M | Micro cap | −26.92% |
| AVE.AX | Avecho Biotechnology Limited | $55.33M | Micro cap | +200.00% |
| 7963.T | Koken Ltd. | $55.27M | Micro cap | +5.49% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| TELY.TO | TelyRx Holdings Inc. | $54.78M | Micro cap | −18.57% |
| ALKLH.PA | KLEA HOLDING | $54.68M | Micro cap | −29.55% |
| ALSMA.PA | S.M.A.I.O S.A. | $54.61M | Micro cap | +13.48% |
| 4571.T | Nano Holdings, Inc. | $54.57M | Micro cap | −30.00% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $54.28M | Micro cap | −47.65% |
| ALTHE.PA | Theraclion SA | $54.11M | Micro cap | −20.00% |
| OHGR.L | One Health Group Plc | $54.00M | Micro cap | +17.03% |
| XSPRAY.ST | Xspray Pharma AB (publ) | $53.87M | Micro cap | −76.41% |
| 4564.T | OncoTherapy Science, Inc. | $53.87M | Micro cap | −25.00% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | $53.78M | Micro cap | +81.25% |
| BTMD | biote Corp. | $53.56M | Micro cap | −51.08% |
| SOM.AX | SomnoMed Limited | $53.50M | Micro cap | −56.13% |
| 000230.KS | Ildong Holdings Co., Ltd. | $53.47M | Micro cap | −27.92% |
| MOB.ST | Moberg Pharma AB (publ) | $53.40M | Micro cap | +24.78% |
| 063160.KS | CKD Bio Corp. | $53.33M | Micro cap | −39.08% |
| HYPD | Hyperion DeFi, Inc. | $52.99M | Micro cap | −44.10% |
| ALA.AX | Arovella Therapeutics Limited | $52.84M | Micro cap | −26.19% |
| MODU.HE | Modulight Oyj | $52.83M | Micro cap | −23.38% |
| HRTIS.HE | Herantis Pharma Oyj | $52.30M | Micro cap | −4.21% |
| CLBIO.ST | Corline Biomedical AB | $52.11M | Micro cap | +46.22% |
| TCRX | TScan Therapeutics, Inc. | $51.87M | Micro cap | −58.23% |
| SCYX | SCYNEXIS, Inc. | $51.64M | Micro cap | +514.20% |
| TIL | Instil Bio, Inc. | $51.54M | Micro cap | −69.62% |
| MDAI | Spectral AI, Inc. | $51.50M | Micro cap | −19.70% |
| 4597.T | Solasia Pharma K.K. | $51.47M | Micro cap | −23.68% |
| 004720.KS | PharmGen Science, Inc. | $51.24M | Micro cap | −27.52% |
| 9218.T | Mental Health Technologies Co.,Ltd. | $51.10M | Micro cap | −5.89% |
| AIFORIA.HE | Aiforia Technologies Oyj | $51.08M | Micro cap | −66.16% |
| M3V.DE | MeVis Medical Solutions AG | $50.58M | Micro cap | −0.42% |
| PTX.AX | Prescient Therapeutics Limited | $50.48M | Micro cap | +58.14% |
| ORX.ST | Orexo AB (publ) | $50.31M | Micro cap | −36.19% |
| CANTA.ST | Cantargia AB (publ) | $50.23M | Micro cap | −28.93% |
| SVS.MI | Svas Biosana S.p.A. | $50.15M | Micro cap | +0.73% |
| PHX.AX | PharmX Technologies Limited | $50.12M | Micro cap | −4.55% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −20.79% |
| 8769.T | Advantage Risk Management Co., Ltd. | $49.53M | Micro cap | −11.34% |
| 002720.KS | Kukje Pharma Co., Ltd. | $49.51M | Micro cap | −29.89% |
| ENZY.ST | Enzymatica AB (publ) | $48.79M | Micro cap | −21.61% |
| 7096.T | StemCell Institute Inc. | $48.78M | Micro cap | −21.54% |
| POCI | Precision Optics Corporation, Inc. | $48.27M | Micro cap | −9.07% |
| NSRX | Nasus Pharma Ltd. | $48.01M | Micro cap | −48.69% |
| M7T.AX | Mach7 Technologies Limited | $47.99M | Micro cap | −9.52% |
| SVE.WA | Synthaverse S.A. | $47.84M | Micro cap | −37.70% |
| IMMU.ST | Mendus AB (publ) | $47.68M | Micro cap | −8.16% |
| 3628.T | Data Horizon Co.,Ltd. | $47.53M | Micro cap | +9.96% |
| QTI | QT Imaging Holdings, Inc. | $47.42M | Micro cap | −90.73% |
| 3671.T | Softmax Co., Ltd | $47.30M | Micro cap | −7.57% |
| CYC.AX | Cyclopharm Limited | $46.85M | Micro cap | −47.50% |
| OSSD.ST | OssDsign AB (publ) | $46.81M | Micro cap | −71.22% |
| MCRB | Seres Therapeutics, Inc. | $46.81M | Micro cap | −74.00% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −26.84% |
| GRCE | Grace Therapeutics, Inc. | $46.28M | Micro cap | −32.31% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $46.25M | Micro cap | −33.75% |
| BIOBV.HE | Biohit Oyj | $46.16M | Micro cap | −8.24% |
| FLNA | Filana Therapeutics, Inc. | $45.83M | Micro cap | −56.07% |
| NEPH | Nephros, Inc. | $45.83M | Micro cap | +0.72% |
| AIAI.TO | NetraMark Holdings Inc. | $45.79M | Micro cap | −59.54% |
| MGX | Metagenomi Therapeutics, Inc. | $45.71M | Micro cap | −35.64% |
| ENP.AX | Entropy Neurodynamics Limited | $45.59M | Micro cap | +5.41% |
| 4890.T | Tsubota Laboratory Incorporated | $45.38M | Micro cap | −23.50% |
| ABLD.PA | ABL Diagnostics Société anonyme | $45.06M | Micro cap | −47.32% |
| MREO | Mereo BioPharma Group plc | $44.97M | Micro cap | −83.82% |
| XTNT | Xtant Medical Holdings, Inc. | $44.88M | Micro cap | −50.02% |
| IXHL | Incannex Healthcare Inc. | $44.87M | Micro cap | −83.13% |
| 3386.T | Cosmo Bio Company,Limited | $44.68M | Micro cap | +6.78% |
| TVGN | Tevogen Inc. | $44.34M | Micro cap | −84.85% |
| 2370.T | MEDINET Co., Ltd. | $44.25M | Micro cap | −34.21% |
| 6059.T | UCHIYAMA HOLDINGS Co.,Ltd. | $43.89M | Micro cap | +12.60% |
| 9340.T | ASO International, Inc. | $43.88M | Micro cap | −1.19% |
| CTE.AX | Cryosite Limited | $43.72M | Micro cap | +56.25% |
| 3750.T | ADR Biomedical Holdings Inc. | $43.59M | Micro cap | −15.61% |
| ALCOX.PA | Nicox S.A. | $43.20M | Micro cap | +4.08% |
| 4880.T | CellSource Co., Ltd. | $43.15M | Micro cap | −41.78% |
| ALNOV.PA | Novacyt S.A. | $43.09M | Micro cap | +8.44% |
| NCYT.L | Novacyt S.A. | $43.04M | Micro cap | +9.18% |
| MLSS | Milestone Scientific Inc. | $43.04M | Micro cap | −17.80% |
| HOWL | Werewolf Therapeutics, Inc. | $42.93M | Micro cap | −35.04% |
| EDSA | Edesa Biotech, Inc. | $42.90M | Micro cap | +83.88% |
| 4583.T | Chiome Bioscience Inc. | $42.82M | Micro cap | −36.57% |
| 000220.KS | Yuyu Pharma, Inc. | $42.74M | Micro cap | −11.54% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.